Last 7 days
-9.5%
Last 30 days
-15.0%
Last 90 days
-3.8%
Trailing 12 Months
-40.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 40.4B | 6.8B | -13.31% | 3.22% | 32.19 | 5.89 | 8.37% | 3.64% |
ILMN | 35.5B | 4.6B | 5.65% | -27.02% | -8.07 | 7.75 | 1.28% | -677.95% |
MTD | 32.5B | 3.9B | -7.42% | 9.05% | 37.3 | 8.3 | 5.43% | 13.46% |
WAT | 18.2B | 3.0B | -10.97% | -4.88% | 25.66 | 6.11 | 6.68% | 2.15% |
PKI | 15.9B | 3.3B | -11.65% | -27.44% | 27.98 | 4.81 | -34.64% | -39.65% |
MID-CAP | ||||||||
SMALL-CAP | ||||||||
PACB | 2.0B | 128.3M | -11.70% | -1.09% | -6.37 | 15.61 | -1.69% | -73.40% |
ADPT | 1.2B | 185.3M | -5.41% | -23.53% | -6 | 6.49 | 20.06% | 3.42% |
QTRX | 450.3M | 105.5M | -12.44% | -50.56% | -4.66 | 4.27 | -4.55% | -67.63% |
NSTG | 405.5M | 127.3M | -23.43% | -69.17% | -2.54 | 3.19 | -12.28% | -38.43% |
BNGO | 341.8M | 27.8M | -23.57% | -31.43% | -2.58 | 12.29 | 54.62% | -83.06% |
CDXS | 271.1M | 138.6M | -29.13% | -76.08% | -8.07 | 1.96 | 32.30% | -57.86% |
PSNL | 135.5M | 65.0M | -20.46% | -63.49% | -1.2 | 2.08 | -23.92% | -73.73% |
HBIO | 117.4M | 113.3M | -15.92% | -55.18% | -12.34 | 1.04 | -4.68% | -3204.17% |
CSBR | 54.2M | 54.1M | -0.24% | -45.98% | 502.17 | 1 | 21.80% | -72.38% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -1.5% | 7,512 | 7,625 | 7,603 | 7,551 | 7,386 |
Gross Profit | -1.3% | 2,603 | 2,636 | 2,601 | 2,580 | 2,503 |
S&GA Expenses | -4.6% | 1,473 | 1,543 | 1,547 | 1,567 | 1,531 |
EBITDA | 2.7% | 1,522 | 1,482 | 1,447 | 1,419 | - |
EBITDA Margin | 4.3% | 0.20* | 0.19* | 0.19* | 0.19* | - |
Earnings Before Taxes | 4.3% | 851 | 816 | 795 | 783 | 753 |
EBT Margin | 5.8% | 0.11* | 0.11* | 0.10* | 0.10* | - |
Interest Expenses | 3.5% | 266 | 257 | 244 | 231 | 217 |
Net Income | 7.5% | 687 | 639 | 629 | 599 | 573 |
Net Income Margin | 9.1% | 0.09* | 0.08* | 0.08* | 0.08* | - |
Free Cahsflow | -11.1% | 710 | 799 | 809 | 858 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 2.7% | 13,464 | 13,113 | 13,431 | 13,836 | 13,897 |
Current Assets | 3.8% | 2,658 | 2,560 | 2,572 | 2,606 | 2,477 |
Cash Equivalents | 40.4% | 373 | 266 | 238 | 284 | 302 |
Inventory | 0.9% | 914 | 905 | 923 | 896 | 872 |
Net PPE | 4.1% | 727 | 698 | 698 | 700 | 706 |
Goodwill | 2.6% | 5,653 | 5,511 | 5,626 | 5,265 | 5,341 |
Liabilities | 1.0% | 8,609 | 8,522 | 8,961 | 9,478 | 9,700 |
Current Liabilities | 6.9% | 1,659 | 1,552 | 1,571 | 1,447 | 1,451 |
Long Term Debt | - | 7,023 | - | - | - | - |
LT Debt, Current | 29.8% | 364 | 281 | 246 | 45.00 | 45.00 |
LT Debt, Non Current | 0.3% | 5,923 | 5,908 | 6,293 | 6,816 | 6,978 |
Shareholder's Equity | 5.7% | 4,855 | 4,591 | 4,470 | 4,358 | 4,197 |
Retained Earnings | 13.8% | 1,170 | 1,029 | 862 | 674 | 484 |
Accumulated Depreciation | 6.1% | 518 | 489 | 474 | 463 | 445 |
Shares Outstanding | 0.0% | 674 | 674 | 674 | 610 | 610 |
Float | - | 20,730 | - | - | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -10.2% | 844 | 939 | 943 | 979 | 954 |
Share Based Compensation | -7.5% | 46.00 | 50.00 | 51.00 | 50.00 | 51.00 |
Cashflow From Investing | 96.3% | -109 | -2,960 | -2,998 | -4,146 | -4,121 |
Cashflow From Financing | -172.6% | -648 | 894 | 2,094 | 3,313 | 3,219 |
66.8%
49.0%
38.6%
Y-axis is the maximum loss one would have experienced if Avantor was unfortunately bought at previous high price.
20.2%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 18.45 | 1,765,930 | 8,200,930 | 0.01% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 5.36 | 472,194 | 4,001,190 | 0.25% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 11.76 | 81,000 | 483,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -2.98 | 4,679,250 | 111,065,000 | 0.16% |
2023-02-24 | NATIXIS | new | - | 14,172 | 14,172 | -% |
2023-02-24 | National Pension Service | added | 16.47 | 4,610,260 | 25,956,800 | 0.05% |
2023-02-24 | SRS Capital Advisors, Inc. | unchanged | - | 1,102 | 10,102 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 667,000 | 9,447,000 | 0.10% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -57.52 | -65,745 | 55,255 | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -18.99 | -554,234 | 3,767,770 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 11.3% | 76,325,881 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 5.8% | 38,913,266 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.16% | 61,754,847 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 5.8% | 39,358,674 | SC 13G/A | |
Nov 10, 2022 | t. rowe price investment management, inc. | 10.2% | 69,067,643 | SC 13G | |
Mar 11, 2022 | blackrock inc. | 7.1% | 43,769,070 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 12.2% | 74,859,221 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.26% | 50,319,888 | SC 13G/A | |
Feb 08, 2022 | blackrock inc. | 7.1% | 43,769,070 | SC 13G | |
Jan 31, 2022 | invesco ltd. | 4.2% | 25,419,453 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 10.37 -50.95% | 14.15 -33.07% | 18.48 -12.58% | 23.80 12.58% | 28.96 36.99% |
Current Inflation | 9.66 -54.30% | 12.91 -38.93% | 16.54 -21.76% | 21.00 -0.66% | 25.33 19.82% |
Very High Inflation | 8.77 -58.51% | 11.41 -46.03% | 14.24 -32.64% | 17.73 -16.13% | 21.13 -0.05% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 06, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | Brophy Gerard | sold | -97,850 | 25.00 | -3,914 | evp, biopharma production |
2023-02-28 | Couturier Christophe | sold | -56,519 | 24.32 | -2,324 | evp, amea |
2023-02-27 | Brophy Gerard | sold | -76,475 | 25.00 | -3,059 | evp, biopharma production |
2023-02-25 | Eck Steven W | sold (taxes) | -12,433 | 24.62 | -505 | svp & chief accounting officer |
2023-02-25 | Couturier Christophe | sold (taxes) | -11,497 | 24.62 | -467 | evp, amea |
2023-02-25 | Brophy Gerard | sold (taxes) | -50,224 | 24.62 | -2,040 | evp, biopharma production |
2023-02-25 | Szlosek Thomas A | sold (taxes) | -50,224 | 24.62 | -2,040 | evp & cfo |
2023-02-25 | Henson Meghan | sold (taxes) | -19,696 | 24.62 | -800 | evp, chief hr officer |
2023-02-25 | Miller Justin | sold (taxes) | -13,787 | 24.62 | -560 | evp & general counsel |
2023-02-25 | Bramwell James | sold (taxes) | -12,580 | 24.62 | -511 | evp, americas |
Consolidated statements of operations - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statements of operations | |||
Net sales | $ 7,512.4 | $ 7,386.1 | $ 6,393.6 |
Cost of sales | 4,909.6 | 4,883.4 | 4,313.1 |
Gross profit | 2,602.8 | 2,502.7 | 2,080.5 |
Selling, general and administrative expenses | 1,472.6 | 1,530.5 | 1,373.7 |
Operating income | 1,130.2 | 972.2 | 706.8 |
Interest expense | (265.8) | (217.4) | (307.6) |
Loss on extinguishment of debt | (12.5) | (12.4) | (346.8) |
Other (expense) income, net | (0.8) | 10.6 | 9.9 |
Income before income taxes | 851.1 | 753.0 | 62.3 |
Income tax (expense) benefit | (164.6) | (180.4) | 54.3 |
Net income | 686.5 | 572.6 | 116.6 |
Accumulation of yield on preferred stock | (24.2) | (64.6) | (64.6) |
Net income available to common stockholders | $ 662.3 | $ 508.0 | $ 52.0 |
Earnings per share: | |||
Basic | $ 1.02 | $ 0.86 | $ 0.09 |
Diluted | $ 1.01 | $ 0.85 | $ 0.09 |
Weighted average shares outstanding: | |||
Basic | 650.9 | 590.5 | 576.3 |
Diluted | 679.4 | 599.6 | 583.4 |
Consolidated balance sheets - USD ($) shares in Millions, $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Assets | ||
Cash and cash equivalents | $ 372.9 | $ 301.7 |
Accounts receivable, net of allowances of $28.2 and $26.4 | 1,218.4 | 1,222.1 |
Inventory | 913.5 | 872.0 |
Other current assets | 153.1 | 81.4 |
Total current assets | 2,657.9 | 2,477.2 |
Property, plant and equipment, net of accumulated depreciation of $518.4 and $445.2 | 727.0 | 705.5 |
Other intangible assets, net (see note 11) | 4,133.3 | 5,140.3 |
Goodwill | 5,652.6 | 5,341.1 |
Other assets | 293.5 | 233.1 |
Total assets | 13,464.3 | 13,897.2 |
Liabilities and stockholders’ equity | ||
Current portion of debt | 364.2 | 45.2 |
Accounts payable | 758.2 | 755.1 |
Employee-related liabilities | 122.4 | 199.7 |
Accrued interest | 49.9 | 49.8 |
Other current liabilities | 364.1 | 401.0 |
Total current liabilities | 1,658.8 | 1,450.8 |
Debt, net of current portion | 5,923.3 | 6,978.0 |
Deferred income tax liabilities | 731.4 | 913.0 |
Other liabilities | 295.4 | 358.4 |
Total liabilities | 8,608.9 | 9,700.2 |
Commitments and contingencies (see note 13) | ||
MCPS including paid-in capital, 0.0 and 20.7 shares outstanding | 0.0 | 1,003.7 |
Common stock including paid-in capital, 674.3 and 609.7 shares outstanding | 3,785.3 | 2,752.6 |
Accumulated earnings | 1,170.4 | 483.9 |
Accumulated other comprehensive loss | (100.3) | (43.2) |
Total stockholders’ equity | 4,855.4 | 4,197.0 |
Total liabilities and stockholders’ equity | $ 13,464.3 | $ 13,897.2 |
Preferred equity, shares outstanding | 0.0 | 20.7 |